La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « Parkinson Disease (economics) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Parkinson Disease (drug therapy) < Parkinson Disease (economics) < Parkinson Disease (enzymology)  Facettes :

List of bibliographic references indexed by Parkinson Disease (economics)

Number of relevant bibliographic references: 13.
Ident.Authors (with country if any)Title
000581 (2015) Alberto J. Espay ; Matthew M. Norris ; James C. Eliassen ; Alok Dwivedi ; Matthew S. Smith ; Christi Banks ; Jane B. Allendorfer ; Anthony E. Lang ; David E. Fleck ; Michael J. Linke ; Jerzy P. SzaflarskiPlacebo effect of medication cost in Parkinson disease
000977 (2014) Suzy L. Wong ; Heather Gilmour ; Pamela L. Ramage-MorinParkinson's disease: Prevalence, diagnosis and impact.
000A48 (2014) Vincent A. Jourdain [Canada] ; Gast N SchechtmannHealth economics and surgical treatment for Parkinson's disease in a world perspective: results from an international survey.
002197 (2008) Doug Coyle [Canada] ; Jeremy OakleyEstimating the expected value of partial perfect information: a review of methods.
002D59 (2003) D. Coyle [Canada] ; M. Barbeau ; M. Guttman ; J-F BaladiThe economic evaluation of pharmacotherapies for Parkinson's disease.
002E83 (2003) Mark Guttman [Canada] ; Pamela M. Slaughter [Canada] ; Marc-Erick Theriault [Canada] ; Donald P. Deboer [Canada] ; C. David Naylor [Canada]Burden of parkinsonism: A population‐based study
002F23 (2003) Douglas Coyle [Canada] ; Martin J. Buxton [Royaume-Uni] ; Bernie J. O'Brien [Canada]Measures of importance for economic analysis based on decision modeling
002F43 (2003) Michael Iskedjian [Canada] ; Thomas R. Einarson [Canada]Cost analysis of ropinirole versus levodopa in the treatment of Parkinson's disease
003062 (2002) M. Guttman [Canada] ; P. M. Slaughter [Canada] ; M.-E. Theriault [Canada] ; D. P. Deboer [Canada] ; C. D. Naylor [Canada]Parkinsonism in Ontario: Physician utilization
003107 (2001) T. Muir ; M. ZegaracSocietal costs of exposure to toxic substances: economic and health costs of four case studies that are candidates for environmental causation.
003372 (2000) L. McauleyEntacapone: adjunctive use in patients with advanced Parkinson's disease.
003808 (1999) M. Guttman [Canada] ; O. Suchowersky [Canada]Parkinson's disease management : Towards a new paradigm
003849 (1998) D. Hailey [Canada] ; C. HarstallPosteroventral pallidotomy for Parkinson's disease: assessment and policy on a technology in transition.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Parkinson Disease (economics)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Parkinson Disease (economics)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Parkinson Disease (economics)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022